Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Predictive Oncology Inc (NQ: POAI )

0.7691 +0.0491 (+6.82%)
Streaming Delayed Price Updated: 1:48 PM EST, Nov 25, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Predictive Oncology Inc

< Previous 1 2 3 4 Next >
Predictive Oncology Reports Third Quarter 2024 Financial Results and Provides Strategic Update
Company initiates process to explore a broad range of strategic alternatives to maximize shareholder value 
From Predictive Oncology Inc.
Via GlobeNewswire
InvestorNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Announces Participation at the H.C. Wainwright 26th Annual Global Investment Conference
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence
Predictive Oncology to Present at the H.C. Wainwright 26th Annual Global Investment Conference
From Predictive Oncology Inc.
Via GlobeNewswire
TinyGemsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Reports on Study Confirming Long-Term Stability, Viability of Proprietary Tumor Specimen Biobank
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence
Predictive Oncology Study Demonstrates Long-Term Stability and Viability of Proprietary Biobank of Primary Tumor Specimens for Pharmaceutical Drug Discovery
From Predictive Oncology Inc.
Via GlobeNewswire
InvestorNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Announces Q2 2024 Financial Results, Provides Business Update
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence
Predictive Oncology Reports Second Quarter 2024 Financial Results and Provides Business Update
Company to host investor call and webcast today, August 14th, at 8:30am EDT 
From Predictive Oncology Inc.
Via GlobeNewswire
BioMedNewsBreaks — Predictive Oncology Inc. (NASDAQ: POAI) Announces Expansion of Live-Cell Tumor Platform Applications
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence
Predictive Oncology Expands the Application of its Live-Cell Tumor Platform to De-Risk Drug Discovery and Accelerate Pipeline Development
From Predictive Oncology Inc.
Via GlobeNewswire
AINewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Schedules Release of Q2 2024 Financial Results, Conference Call
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence
Predictive Oncology to Report Second Quarter 2024 Financial Results on Wednesday, August 14, 2024
Management to host conference call and webcast at 8:30am ET 
From Predictive Oncology Inc.
Via GlobeNewswire
AINewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Enters into $1.2M Agreement for Exercise of Warrants
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence
Predictive Oncology Announces Exercise of Warrants for $1.26 Million Gross Proceeds
From Predictive Oncology Inc.
Via GlobeNewswire
InvestorNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Expands Its AI/ML Driven Platform to Include Novel Oncology Biomarker Discovery
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence
Predictive Oncology Enters Biomarker Discovery Market After Successful Retrospective Ovarian Cancer Study Yields Compelling Results
From Predictive Oncology Inc.
Via GlobeNewswire
InvestorNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Unveils Novel Technology, Eyes Significant Partnership Opportunities
Via Investor Brand Network
Topics Artificial Intelligence Intellectual Property
Exposures Artificial Intelligence Intellectual Property
Predictive Oncology Develops Novel Stem Cell Expression System for the Production of Functional and Stable G-Protein Coupled Receptors (GPCRs)
From Predictive Oncology Inc.
Via GlobeNewswire
InvestorNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Launches Novel Technology to Accelerate Cancer Drug Discovery, Development
Via Investor Brand Network
Topics Animal Testing Artificial Intelligence
Exposures Animal Testing Artificial Intelligence
Predictive Oncology Launches Novel 3D Cell Technology to Accelerate Cancer Therapeutic Drug Discovery
From Predictive Oncology Inc.
Via GlobeNewswire
TinyGemsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) CEO to Participate at Upcoming BIO International Convention 2024
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence
Predictive Oncology Announces CEO Raymond Vennare to Present at the BIO International Convention 2024
Presentation to highlight Company’s novel application of AI/machine learning capabilities utilizing its proprietary biobank of more than 150,000 tumor samples to guide leading biopharma partners... 
From Predictive Oncology Inc.
Via GlobeNewswire
TinyGemsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Announces Positive Results from Ovarian Cancer Study
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence
Predictive Oncology Announces Positive Results from Ovarian Cancer Study with UPMC Magee-Womens Hospital to be Presented at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
Study successfully demonstrated Predictive’s ability to build AI multi-omic machine learning models to predict survival outcomes among ovarian cancer patients better than clinical data alone 
From Predictive Oncology Inc.
Via GlobeNewswire
BioMedNewsBreaks — Predictive Oncology Inc. (NASDAQ: POAI) Announces Q1 2024 Financial Results, Provides Business Update
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence
Predictive Oncology Reports First Quarter 2024 Financial Results and Provides Business Update
Company to host investor call and webcast today, May 15th, at 8:30am EDT 
From Predictive Oncology Inc.
Via GlobeNewswire
InvestorNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Schedules Release of Q1 2024 Financial Results, Conference Call
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence
Predictive Oncology to Report First Quarter 2024 Financial Results on Wednesday, May 15, 2024
Management to host conference call and webcast at 8:30am ET 
From Predictive Oncology Inc.
Via GlobeNewswire
BioMedNewsBreaks — Predictive Oncology Inc. (NASDAQ: POAI) Partners with FluGen to Develop First-of-Its-Kind Intranasal Flu Vaccine for Global Distribution
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence
Predictive Oncology Announces Significant Progress with FluGen In the Development of First-of-Its-Kind Intranasal Flu Vaccine
From Predictive Oncology Inc.
Via GlobeNewswire
TinyGemsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Abstract to Be Presented Next Month at ASCO Annual Meeting
Via Investor Brand Network
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.